Eli Lilly growth tied to nascent diabetes drug sales Ruchika Sharma1 Nov 2022 10:15 AM ISTUS: Wall Street analysts will be focusing on sales of Eli Lilly and Co's newly approved diabetes drug Mounjaro when the company reports results on...
Lilly to acquire Akouos for Hearing Loss treatments Ruchika Sharma19 Oct 2022 3:30 PM ISTUnder the terms of the transaction, Lilly will acquire all of the outstanding shares of Akouos for $12.50 per share in cash, plus one contingent value...
Eli Lilly gets USFDA Fast Track designation for Tirzepatide to treat adults with obesity Ruchika Sharma7 Oct 2022 12:15 PM ISTTirzepatide is a once-weekly GIP (glucose-dependent insulinotropic polypeptide) receptor and GLP-1 (glucagon-like peptide-1) receptor agonist.
Thermo Fisher Scientific bags USFDA nod for NGS-based CDx Test for lung, thyroid cancers Ruchika Sharma28 Sept 2022 12:45 PM ISTThe Oncomine Dx Target test is a next-generation sequencing (NGS)-based test that can detect multiple alterations at once from a small sample size,...
USFDA nod to Eli Lilly RET Inhibitor Retevmo for adults with advanced or metastatic solid tumors with a RET Gene Fusion, regardless of type Ruchika Sharma23 Sept 2022 4:20 PM ISTIn addition to the tumor-agnostic approval, the USFDA has granted traditional approval for Retevmo in adult patients with locally advanced or...
Justify protocol amendments in detail: CDSCO Panel tells Eli Lilly on Trail of Imlunestrant Dr. Divya Colin23 Aug 2022 6:00 PM ISTNew Delhi: In response to the proposed protocol amendment for Eli Lilly's anticancer drug LY348-4356 (Imlunestrant), the Subject Expert Committee...
FIRST: Eli Lilly gets USFDA nod for alopecia areata pill Olumiant Ruchika Sharma14 Jun 2022 1:00 PM ISTOLUMIANT is a once-daily, oral JAK inhibitor discovered by Incyte and licensed to Lilly and is available through specialty pharmacies nationwide.
Eli Lilly sued by whistleblower over drug manufacturing problems Ruchika Sharma8 Jun 2022 3:27 PM ISTThe company also said it "continues to cooperate" with a Justice Department subpoena and to work collaboratively with the U.S. Food and Drug...
Aurobindo Pharma arm bags USFDA nod for Pemetrexed for Injection Ruchika Sharma26 May 2022 1:14 PM ISTPemetrexed for injection is indicated for the treatment of Antineoplastics (medications used to treat cancer)
Eli Lilly Mounjaro injection gets USFDA nod for type 2 diabetes Ruchika Sharma14 May 2022 3:17 PM ISTMounjaro will be available in six doses (2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, 15 mg) and will come in Lilly's auto-injector pen with a pre-attached,...
USFDA nod to Eli Lilly Olumiant for certain hospitalized Covid patients Ruchika Sharma13 May 2022 1:02 PM ISTOLUMIANT is a once-daily, oral JAK inhibitor discovered by Incyte and licensed to Lilly.
Journal Club - Tirzepatide may lead weight loss of up to 23 percent in obese people Dr.B.P.RAHUL9 May 2022 3:33 PM ISTRecent data from SURMOUNT-1 clinical trial showed that tirzepatide achieved superior weight loss compared to a placebo in obese/overweight individuals...
